Newsletter: November 2021
Mainstream Media Starts the Morning with MAPS November 24, 2021 Features about MAPS aired on several morning news shows this month! On November 14, CBS News aired an investigative report about treating …
All News
De toekomst van medicinale mdma ziet er in Nederland veelbelovend uit (The future of medicinal MDMA looks promising in the Netherlands)
In the Netherlands there are almost 150,000 people who suffer from post-traumatic stress disorder (PTSD). They have experienced something so intense that it left them traumatized. As a result, they suffer …
Shrink Speak Podcast: The Future of Psychedelics: A Discussion with Rick Doblin & Steven Levine
Summary: In a new episode of the Shrink Speak Podcast, Dr. Jeffrey Lieberman speaks with MAPS Founder Rick Doblin, Ph.D., and Dr. Steven Levine to explore recent progress in psychedelic research, therapeutic …
CBS News: Using Psychedelics to Treat Veterans’ PTSD
CBS News airs an investigative report about treating PTSD with MDMA-assisted therapy on a new episode of CBS Sunday Morning. In a series of interviews with David Martin of CBS, former Marine Scott Ostrom …
The New York Times: Veterans Have Become Unlikely Lobbyists in Push to Legalize Psychedelic Drugs
The New York Times publishes an in-depth report on Veterans advancing the field of psychedelic medicine, highlighting personal experiences, public advocacy, drug policy reform efforts, and new initiatives …
Red Table Talk with the Smith Family: The Miracle Treatment We Almost Couldn’t Tell You About
Summary: On a new episode of Red Table Talk, Jaden Smith, Jada Pinkett Smith, and Gammy Norris speak with author Michael Pollan, journalist Lisa Ling, oncologist Paul Song, and entrepreneur Bob Parsons …
WIRED: Big Tech’s Psychedelics Grift
Summary: WIRED investigates the growth of support for psychedelic medicine, highlighting how entrepreneurs from the technology industry are contributing to the field through philanthropic contributions …
TODAY Show: New Research Shows How Psychedelic Drug Can Help People With PTSD
MAPS is on The TODAY Show! This morning, NBC educated millions of people about psychedelic science by airing an interview with MAPS Founder Rick Doblin, Ph.D., and MDMA-assisted therapy study participants …
MAPS Announces Appointment of Carl L. Hart, Ph.D., to the Board of Directors
The Multidisciplinary Association for Psychedelic Studies (MAPS) is honored to announce the election of Carl L. Hart, Ph.D., to MAPS’ Board of Directors, effective as of October 22, 2021. Dr. Carl Hart, …
Benzinga: Magic Mushrooms and Ecstasy: New Treatment For Autism Spectrum Disorders?
Summary: Benzinga considers the potential of psilocybin- and MDMA-assisted therapy as treatment options for individuals with autism spectrum disorders, drawing on previous MAPS-sponsored research of MDMA-assisted …
Newsletter: October 2021
Psychedelic Science Expands Through Collaboration New publication in Nature Medicine, expansion of investigator-initiated trials, and new opportunities to contribute October 29, 2021 Dear friends and supporters, …
Phase 3 Trials of MDMA-Assisted Therapy for PTSD: Seeking Research Volunteers
We are currently seeking research volunteers for our second Phase 3 clinical trial of MDMA-assisted therapy for PTSD. We’ve already accrued about 57 of the 100 subjects needed so potential volunteers …